Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.24.2.u1
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Schedule of Potentially Dilutive Securities

The following potentially dilutive securities have been excluded from the computation of diluted shares of common stock outstanding as they would be anti-dilutive:

 

 

    2024     2023  
    June 30,  
    2024     2023  
Common stock warrants August 2021     112,429       128,500  
Underwriter warrants August 2021     2,287       2,287  
Chanticleer warrants     57       57  
Series C warrants     18,391       36,778  
Series 3 warrants     12,548       12,548  
Unvested restricted stock units and awards     137,259       7,840  
Common stock warrants February 2023     271,883       271,883  
Underwriter warrants February 2023     15,466       44,190  
Common stock private placement warrants June 2023     227,272       227,272  
Placement agent warrants June 2023     6,818       6,818  
Common stock warrants October 2023     2,840,000        
Underwriter warrants October 2023     85,312        
Placement agent warrants June 2024     113,140        
Common stock warrants June 2024     5,625,000        
 Total anti-dilutive weighted average shares     9,467,862       738,173